Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | ZTS | TAK | GRFS | SAGE |
| Company | Neurocrine Bioscienc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Grifols S.A. ADR | Sage Therapeutic Com |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 123.00 | 196.80 | 14.87 | 9.02 | 7.49 |
| High | 123.49 | 198.39 | 14.94 | 9.02 | 7.85 |
| Low | 119.37 | 194.37 | 14.77 | 8.69 | 7.32 |
| Last | 119.85 | 196.48 | 14.82 | 8.74 | 7.59 |
| Change | -2.46 | +0.77 | -0.03 | -0.16 | +0.07 |
| % Change | -2.01% | +0.39% | -0.20% | -1.80% | +0.93% |
| Volume | 1,049,100 | 1,993,800 | 1,569,700 | 560,900 | 652,900 |
| 20-Day Average Volume | 1,163,855 | 1,684,655 | 1,655,430 | 1,677,760 | 582,630 |
| Previous Close | 122.31 | 195.71 | 14.85 | 8.90 | 7.52 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 129.93 | 187.35 | 14.89 | 8.87 | 7.86 |
| 20-Day Raw Stochastic | 4.92% | 89.51% | 38.10% | 59.11% | 26.67% |
| 20-Day Relative Strength | 33.90% | 67.91% | 59.07% | 54.78% | 40.16% |
| Weighted Alpha | -4.24 | +15.48 | -0.59 | +25.69 | -67.97 |
| Today's Opinion | 40% Sell | 88% Buy | 72% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 40% Sell | 88% Buy | 72% Buy | 88% Buy | 100% Sell |
| Last Month's Opinion | 100% Buy | 72% Buy | 56% Buy | 32% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.33% since 09/11/24 | +3.42% since 09/11/24 | unch since 09/11/24 | -5.10% since 09/11/24 | +1.34% since 09/11/24 |
| Low | 119.37 on 09/18/24 | 187.14 on 09/12/24 | 14.66 on 09/13/24 | 8.69 on 09/18/24 | 7.27 on 09/12/24 |
| High | 123.57 on 09/16/24 | 198.39 on 09/18/24 | 14.94 on 09/17/24 | 9.35 on 09/13/24 | 7.87 on 09/16/24 |
| 1-Month | |||||
| %Chg | -17.35% since 08/16/24 | +6.95% since 08/16/24 | +2.21% since 08/16/24 | +23.80% since 08/16/24 | -6.76% since 08/16/24 |
| Low | 118.04 on 09/10/24 | 180.18 on 08/23/24 | 14.51 on 08/19/24 | 7.09 on 08/19/24 | 7.19 on 09/10/24 |
| High | 154.87 on 08/23/24 | 198.39 on 09/18/24 | 15.08 on 08/23/24 | 9.57 on 08/29/24 | 8.76 on 08/19/24 |
| 3-Month | |||||
| %Chg | -8.41% since 06/18/24 | +15.81% since 06/18/24 | +16.97% since 06/18/24 | +24.50% since 06/18/24 | -29.40% since 06/18/24 |
| Low | 118.04 on 09/10/24 | 166.45 on 06/26/24 | 12.57 on 06/20/24 | 5.79 on 06/27/24 | 7.19 on 09/10/24 |
| High | 157.98 on 08/01/24 | 198.39 on 09/18/24 | 15.08 on 08/23/24 | 9.57 on 08/29/24 | 13.47 on 07/23/24 |
| 6-Month | |||||
| %Chg | -14.05% since 03/18/24 | +15.11% since 03/18/24 | +1.79% since 03/18/24 | +44.46% since 03/18/24 | -60.82% since 03/18/24 |
| Low | 118.04 on 09/10/24 | 144.80 on 04/22/24 | 12.57 on 06/20/24 | 5.79 on 06/27/24 | 7.19 on 09/10/24 |
| High | 157.98 on 08/01/24 | 198.39 on 09/18/24 | 15.08 on 08/23/24 | 9.57 on 08/29/24 | 20.32 on 03/22/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,308,911 | 89,301,504 | 46,997,832 | 6,119,284 | 452,569 |
| Shares Outstanding, K | 100,637 | 456,295 | 3,164,837 | 687,560 | 60,182 |
| Annual Sales | 1,887,100,000 | 8,544,000,000 | 29,419,960,000 | 7,134,500,000 | 86,460,000 |
| Annual Net Income | 249,700,000 | 2,344,000,000 | 994,060,000 | 64,200,000 | -541,490,000 |
| Last Quarter Sales | 590,200,000 | 2,361,000,000 | 7,731,140,000 | 1,957,700,000 | 8,650,000 |
| Last Quarter Net Income | 65,000,000 | 624,000,000 | 609,590,000 | 15,980,000 | -102,850,000 |
| 60-Month Beta | 0.37 | 0.88 | 0.54 | 0.50 | 0.91 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.63 on 08/01/24 | 1.56 on 08/06/24 | 0.56 on 07/31/24 | 0.02 on 07/30/24 | -1.70 on 07/31/24 |
| Latest Earnings Date | 10/29/24 | 11/07/24 | 10/24/24 | 08/01/24 | 11/05/24 |
| Most Recent Dividend | N/A | 0.432 on 07/18/24 | 0.261 on 09/28/23 | 0.370 on 06/03/21 | N/A |
| Next Ex-Dividends Date | N/A | 07/18/24 | 03/27/24 | 06/03/21 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 36.93 | 35.06 | 9.43 | 0.00 | 0.00 |